nodes	percent_of_prediction	percent_of_DWPC	metapath
Duloxetine—CYP1A2—Zileuton—asthma	0.0451	0.11	CbGbCtD
Duloxetine—CYP2D6—Ciclesonide—asthma	0.0449	0.109	CbGbCtD
Duloxetine—CYP1A2—Zafirlukast—asthma	0.0397	0.0965	CbGbCtD
Duloxetine—CYP2D6—Ipratropium bromide—asthma	0.0372	0.0903	CbGbCtD
Duloxetine—CYP2D6—Zafirlukast—asthma	0.0327	0.0795	CbGbCtD
Duloxetine—CYP1A2—Aminophylline—asthma	0.0326	0.0792	CbGbCtD
Duloxetine—CYP2D6—Formoterol—asthma	0.0316	0.0768	CbGbCtD
Duloxetine—CYP2D6—Arformoterol—asthma	0.0316	0.0768	CbGbCtD
Duloxetine—CYP1A2—Theophylline—asthma	0.0307	0.0745	CbGbCtD
Duloxetine—CYP2D6—Tiotropium—asthma	0.0282	0.0684	CbGbCtD
Duloxetine—CYP2D6—Theophylline—asthma	0.0253	0.0614	CbGbCtD
Duloxetine—CYP2D6—Loratadine—asthma	0.024	0.0582	CbGbCtD
Duloxetine—CYP2D6—Dexamethasone—asthma	0.00829	0.0201	CbGbCtD
Duloxetine—SLC6A2—autonomic nervous system—asthma	0.00453	0.152	CbGeAlD
Duloxetine—HTR2A—vagus nerve—asthma	0.00393	0.132	CbGeAlD
Duloxetine—NPY1R—adrenal cortex—asthma	0.00288	0.0968	CbGeAlD
Duloxetine—HTR2A—autonomic nervous system—asthma	0.00273	0.0915	CbGeAlD
Duloxetine—NPY1R—adrenal gland—asthma	0.00208	0.0699	CbGeAlD
Duloxetine—NPY1R—lung—asthma	0.00182	0.0613	CbGeAlD
Duloxetine—SLC6A3—respiratory system—asthma	0.00145	0.0486	CbGeAlD
Duloxetine—SLC6A4—respiratory system—asthma	0.00133	0.0445	CbGeAlD
Duloxetine—SLC6A2—respiratory system—asthma	0.00117	0.0392	CbGeAlD
Duloxetine—CYP1A2—respiratory system—asthma	0.000897	0.0301	CbGeAlD
Duloxetine—SLC6A3—lung—asthma	0.000768	0.0258	CbGeAlD
Duloxetine—SLC6A2—adrenal gland—asthma	0.000707	0.0237	CbGeAlD
Duloxetine—SLC6A4—lung—asthma	0.000704	0.0236	CbGeAlD
Duloxetine—HTR2A—respiratory system—asthma	0.000701	0.0235	CbGeAlD
Duloxetine—SLC6A2—lung—asthma	0.000619	0.0208	CbGeAlD
Duloxetine—HTR2A—epithelium—asthma	0.000586	0.0197	CbGeAlD
Duloxetine—HTR2A—smooth muscle tissue—asthma	0.000565	0.019	CbGeAlD
Duloxetine—HTR2A—cardiovascular system—asthma	0.000537	0.018	CbGeAlD
Duloxetine—HTR2A—trachea—asthma	0.000518	0.0174	CbGeAlD
Duloxetine—CYP1A2—lung—asthma	0.000476	0.016	CbGeAlD
Duloxetine—HTR2A—adrenal gland—asthma	0.000425	0.0143	CbGeAlD
Duloxetine—HTR2A—lung—asthma	0.000372	0.0125	CbGeAlD
Duloxetine—Shock—Prednisolone—asthma	5.01e-05	0.000132	CcSEcCtD
Duloxetine—Cough—Triamcinolone—asthma	5.01e-05	0.000132	CcSEcCtD
Duloxetine—Anaphylactic shock—Hydrocortisone—asthma	4.97e-05	0.000131	CcSEcCtD
Duloxetine—Oedema—Hydrocortisone—asthma	4.97e-05	0.000131	CcSEcCtD
Duloxetine—Convulsion—Triamcinolone—asthma	4.97e-05	0.000131	CcSEcCtD
Duloxetine—Tachycardia—Prednisolone—asthma	4.97e-05	0.000131	CcSEcCtD
Duloxetine—Convulsion—Methylprednisolone—asthma	4.96e-05	0.000131	CcSEcCtD
Duloxetine—Hypertension—Triamcinolone—asthma	4.95e-05	0.00013	CcSEcCtD
Duloxetine—Hypertension—Methylprednisolone—asthma	4.94e-05	0.00013	CcSEcCtD
Duloxetine—Infection—Hydrocortisone—asthma	4.94e-05	0.00013	CcSEcCtD
Duloxetine—Hyperhidrosis—Prednisolone—asthma	4.92e-05	0.00013	CcSEcCtD
Duloxetine—Shock—Hydrocortisone—asthma	4.89e-05	0.000129	CcSEcCtD
Duloxetine—Myalgia—Triamcinolone—asthma	4.88e-05	0.000129	CcSEcCtD
Duloxetine—Nervous system disorder—Hydrocortisone—asthma	4.88e-05	0.000128	CcSEcCtD
Duloxetine—Arthralgia—Methylprednisolone—asthma	4.87e-05	0.000128	CcSEcCtD
Duloxetine—Myalgia—Methylprednisolone—asthma	4.87e-05	0.000128	CcSEcCtD
Duloxetine—Eye disorder—Prednisone—asthma	4.87e-05	0.000128	CcSEcCtD
Duloxetine—Anxiety—Methylprednisolone—asthma	4.86e-05	0.000128	CcSEcCtD
Duloxetine—Tachycardia—Hydrocortisone—asthma	4.85e-05	0.000128	CcSEcCtD
Duloxetine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	4.84e-05	0.000127	CcSEcCtD
Duloxetine—Flushing—Prednisone—asthma	4.83e-05	0.000127	CcSEcCtD
Duloxetine—Skin disorder—Hydrocortisone—asthma	4.83e-05	0.000127	CcSEcCtD
Duloxetine—Ill-defined disorder—Betamethasone—asthma	4.83e-05	0.000127	CcSEcCtD
Duloxetine—Ill-defined disorder—Dexamethasone—asthma	4.83e-05	0.000127	CcSEcCtD
Duloxetine—Discomfort—Triamcinolone—asthma	4.83e-05	0.000127	CcSEcCtD
Duloxetine—Discomfort—Methylprednisolone—asthma	4.82e-05	0.000127	CcSEcCtD
Duloxetine—Hyperhidrosis—Hydrocortisone—asthma	4.81e-05	0.000127	CcSEcCtD
Duloxetine—Dry mouth—Triamcinolone—asthma	4.78e-05	0.000126	CcSEcCtD
Duloxetine—Angioedema—Betamethasone—asthma	4.76e-05	0.000125	CcSEcCtD
Duloxetine—Angioedema—Dexamethasone—asthma	4.76e-05	0.000125	CcSEcCtD
Duloxetine—Anorexia—Hydrocortisone—asthma	4.74e-05	0.000125	CcSEcCtD
Duloxetine—Angiopathy—Prednisone—asthma	4.72e-05	0.000124	CcSEcCtD
Duloxetine—Confusional state—Methylprednisolone—asthma	4.71e-05	0.000124	CcSEcCtD
Duloxetine—Immune system disorder—Prednisone—asthma	4.7e-05	0.000124	CcSEcCtD
Duloxetine—Malaise—Dexamethasone—asthma	4.69e-05	0.000124	CcSEcCtD
Duloxetine—Malaise—Betamethasone—asthma	4.69e-05	0.000124	CcSEcCtD
Duloxetine—Anaphylactic shock—Triamcinolone—asthma	4.68e-05	0.000123	CcSEcCtD
Duloxetine—Oedema—Triamcinolone—asthma	4.68e-05	0.000123	CcSEcCtD
Duloxetine—Vertigo—Dexamethasone—asthma	4.68e-05	0.000123	CcSEcCtD
Duloxetine—Vertigo—Betamethasone—asthma	4.68e-05	0.000123	CcSEcCtD
Duloxetine—Anaphylactic shock—Methylprednisolone—asthma	4.67e-05	0.000123	CcSEcCtD
Duloxetine—Syncope—Dexamethasone—asthma	4.67e-05	0.000123	CcSEcCtD
Duloxetine—Syncope—Betamethasone—asthma	4.67e-05	0.000123	CcSEcCtD
Duloxetine—Arrhythmia—Prednisone—asthma	4.65e-05	0.000123	CcSEcCtD
Duloxetine—Infection—Triamcinolone—asthma	4.65e-05	0.000122	CcSEcCtD
Duloxetine—Infection—Methylprednisolone—asthma	4.64e-05	0.000122	CcSEcCtD
Duloxetine—Shock—Triamcinolone—asthma	4.61e-05	0.000121	CcSEcCtD
Duloxetine—Insomnia—Prednisolone—asthma	4.61e-05	0.000121	CcSEcCtD
Duloxetine—Alopecia—Prednisone—asthma	4.6e-05	0.000121	CcSEcCtD
Duloxetine—Shock—Methylprednisolone—asthma	4.6e-05	0.000121	CcSEcCtD
Duloxetine—Nervous system disorder—Methylprednisolone—asthma	4.58e-05	0.000121	CcSEcCtD
Duloxetine—Loss of consciousness—Betamethasone—asthma	4.58e-05	0.00012	CcSEcCtD
Duloxetine—Loss of consciousness—Dexamethasone—asthma	4.58e-05	0.00012	CcSEcCtD
Duloxetine—Paraesthesia—Prednisolone—asthma	4.57e-05	0.00012	CcSEcCtD
Duloxetine—Tachycardia—Triamcinolone—asthma	4.57e-05	0.00012	CcSEcCtD
Duloxetine—Mental disorder—Prednisone—asthma	4.56e-05	0.00012	CcSEcCtD
Duloxetine—Tachycardia—Methylprednisolone—asthma	4.56e-05	0.00012	CcSEcCtD
Duloxetine—Skin disorder—Methylprednisolone—asthma	4.54e-05	0.000119	CcSEcCtD
Duloxetine—Malnutrition—Prednisone—asthma	4.53e-05	0.000119	CcSEcCtD
Duloxetine—Erythema—Prednisone—asthma	4.53e-05	0.000119	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Hydrocortisone—asthma	4.53e-05	0.000119	CcSEcCtD
Duloxetine—Hyperhidrosis—Triamcinolone—asthma	4.53e-05	0.000119	CcSEcCtD
Duloxetine—Hyperhidrosis—Methylprednisolone—asthma	4.52e-05	0.000119	CcSEcCtD
Duloxetine—Convulsion—Dexamethasone—asthma	4.51e-05	0.000119	CcSEcCtD
Duloxetine—Convulsion—Betamethasone—asthma	4.51e-05	0.000119	CcSEcCtD
Duloxetine—Insomnia—Hydrocortisone—asthma	4.5e-05	0.000118	CcSEcCtD
Duloxetine—Hypertension—Dexamethasone—asthma	4.49e-05	0.000118	CcSEcCtD
Duloxetine—Hypertension—Betamethasone—asthma	4.49e-05	0.000118	CcSEcCtD
Duloxetine—Paraesthesia—Hydrocortisone—asthma	4.47e-05	0.000118	CcSEcCtD
Duloxetine—Myalgia—Betamethasone—asthma	4.43e-05	0.000117	CcSEcCtD
Duloxetine—Myalgia—Dexamethasone—asthma	4.43e-05	0.000117	CcSEcCtD
Duloxetine—Anxiety—Betamethasone—asthma	4.42e-05	0.000116	CcSEcCtD
Duloxetine—Anxiety—Dexamethasone—asthma	4.42e-05	0.000116	CcSEcCtD
Duloxetine—Discomfort—Betamethasone—asthma	4.38e-05	0.000115	CcSEcCtD
Duloxetine—Discomfort—Dexamethasone—asthma	4.38e-05	0.000115	CcSEcCtD
Duloxetine—Dyspepsia—Hydrocortisone—asthma	4.38e-05	0.000115	CcSEcCtD
Duloxetine—Pain—Prednisolone—asthma	4.35e-05	0.000115	CcSEcCtD
Duloxetine—Decreased appetite—Hydrocortisone—asthma	4.32e-05	0.000114	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Hydrocortisone—asthma	4.29e-05	0.000113	CcSEcCtD
Duloxetine—Fatigue—Hydrocortisone—asthma	4.29e-05	0.000113	CcSEcCtD
Duloxetine—Vision blurred—Prednisone—asthma	4.27e-05	0.000113	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Triamcinolone—asthma	4.27e-05	0.000112	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Methylprednisolone—asthma	4.26e-05	0.000112	CcSEcCtD
Duloxetine—Pain—Hydrocortisone—asthma	4.25e-05	0.000112	CcSEcCtD
Duloxetine—Anaphylactic shock—Betamethasone—asthma	4.25e-05	0.000112	CcSEcCtD
Duloxetine—Anaphylactic shock—Dexamethasone—asthma	4.25e-05	0.000112	CcSEcCtD
Duloxetine—Oedema—Dexamethasone—asthma	4.25e-05	0.000112	CcSEcCtD
Duloxetine—Oedema—Betamethasone—asthma	4.25e-05	0.000112	CcSEcCtD
Duloxetine—Insomnia—Triamcinolone—asthma	4.23e-05	0.000112	CcSEcCtD
Duloxetine—Insomnia—Methylprednisolone—asthma	4.23e-05	0.000111	CcSEcCtD
Duloxetine—Infection—Betamethasone—asthma	4.22e-05	0.000111	CcSEcCtD
Duloxetine—Infection—Dexamethasone—asthma	4.22e-05	0.000111	CcSEcCtD
Duloxetine—Ill-defined disorder—Prednisone—asthma	4.21e-05	0.000111	CcSEcCtD
Duloxetine—Paraesthesia—Triamcinolone—asthma	4.2e-05	0.000111	CcSEcCtD
Duloxetine—Feeling abnormal—Prednisolone—asthma	4.2e-05	0.00011	CcSEcCtD
Duloxetine—Paraesthesia—Methylprednisolone—asthma	4.2e-05	0.00011	CcSEcCtD
Duloxetine—Anaemia—Prednisone—asthma	4.19e-05	0.00011	CcSEcCtD
Duloxetine—Shock—Betamethasone—asthma	4.18e-05	0.00011	CcSEcCtD
Duloxetine—Shock—Dexamethasone—asthma	4.18e-05	0.00011	CcSEcCtD
Duloxetine—Nervous system disorder—Betamethasone—asthma	4.17e-05	0.00011	CcSEcCtD
Duloxetine—Nervous system disorder—Dexamethasone—asthma	4.17e-05	0.00011	CcSEcCtD
Duloxetine—Agitation—Prednisone—asthma	4.17e-05	0.00011	CcSEcCtD
Duloxetine—Thrombocytopenia—Dexamethasone—asthma	4.16e-05	0.00011	CcSEcCtD
Duloxetine—Thrombocytopenia—Betamethasone—asthma	4.16e-05	0.00011	CcSEcCtD
Duloxetine—Tachycardia—Dexamethasone—asthma	4.15e-05	0.000109	CcSEcCtD
Duloxetine—Tachycardia—Betamethasone—asthma	4.15e-05	0.000109	CcSEcCtD
Duloxetine—Angioedema—Prednisone—asthma	4.14e-05	0.000109	CcSEcCtD
Duloxetine—Dyspepsia—Triamcinolone—asthma	4.12e-05	0.000109	CcSEcCtD
Duloxetine—Dyspepsia—Methylprednisolone—asthma	4.11e-05	0.000108	CcSEcCtD
Duloxetine—Hyperhidrosis—Dexamethasone—asthma	4.11e-05	0.000108	CcSEcCtD
Duloxetine—Hyperhidrosis—Betamethasone—asthma	4.11e-05	0.000108	CcSEcCtD
Duloxetine—Feeling abnormal—Hydrocortisone—asthma	4.1e-05	0.000108	CcSEcCtD
Duloxetine—Malaise—Prednisone—asthma	4.09e-05	0.000108	CcSEcCtD
Duloxetine—Vertigo—Prednisone—asthma	4.07e-05	0.000107	CcSEcCtD
Duloxetine—Gastrointestinal pain—Hydrocortisone—asthma	4.07e-05	0.000107	CcSEcCtD
Duloxetine—Syncope—Prednisone—asthma	4.07e-05	0.000107	CcSEcCtD
Duloxetine—Anorexia—Dexamethasone—asthma	4.05e-05	0.000107	CcSEcCtD
Duloxetine—Anorexia—Betamethasone—asthma	4.05e-05	0.000107	CcSEcCtD
Duloxetine—Urticaria—Prednisolone—asthma	4.04e-05	0.000107	CcSEcCtD
Duloxetine—Fatigue—Triamcinolone—asthma	4.04e-05	0.000106	CcSEcCtD
Duloxetine—Fatigue—Methylprednisolone—asthma	4.03e-05	0.000106	CcSEcCtD
Duloxetine—Pain—Triamcinolone—asthma	4e-05	0.000105	CcSEcCtD
Duloxetine—Loss of consciousness—Prednisone—asthma	3.98e-05	0.000105	CcSEcCtD
Duloxetine—Urticaria—Hydrocortisone—asthma	3.95e-05	0.000104	CcSEcCtD
Duloxetine—Abdominal pain—Hydrocortisone—asthma	3.93e-05	0.000104	CcSEcCtD
Duloxetine—Body temperature increased—Hydrocortisone—asthma	3.93e-05	0.000104	CcSEcCtD
Duloxetine—Convulsion—Prednisone—asthma	3.93e-05	0.000103	CcSEcCtD
Duloxetine—Hypertension—Prednisone—asthma	3.91e-05	0.000103	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Dexamethasone—asthma	3.87e-05	0.000102	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Betamethasone—asthma	3.87e-05	0.000102	CcSEcCtD
Duloxetine—Arthralgia—Prednisone—asthma	3.86e-05	0.000102	CcSEcCtD
Duloxetine—Myalgia—Prednisone—asthma	3.86e-05	0.000102	CcSEcCtD
Duloxetine—Feeling abnormal—Triamcinolone—asthma	3.86e-05	0.000102	CcSEcCtD
Duloxetine—Feeling abnormal—Methylprednisolone—asthma	3.85e-05	0.000101	CcSEcCtD
Duloxetine—Anxiety—Prednisone—asthma	3.85e-05	0.000101	CcSEcCtD
Duloxetine—Insomnia—Dexamethasone—asthma	3.84e-05	0.000101	CcSEcCtD
Duloxetine—Insomnia—Betamethasone—asthma	3.84e-05	0.000101	CcSEcCtD
Duloxetine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	3.83e-05	0.000101	CcSEcCtD
Duloxetine—Gastrointestinal pain—Methylprednisolone—asthma	3.82e-05	0.000101	CcSEcCtD
Duloxetine—Paraesthesia—Betamethasone—asthma	3.81e-05	0.0001	CcSEcCtD
Duloxetine—Paraesthesia—Dexamethasone—asthma	3.81e-05	0.0001	CcSEcCtD
Duloxetine—Discomfort—Prednisone—asthma	3.81e-05	0.0001	CcSEcCtD
Duloxetine—Hypersensitivity—Prednisolone—asthma	3.75e-05	9.88e-05	CcSEcCtD
Duloxetine—Dyspepsia—Dexamethasone—asthma	3.74e-05	9.85e-05	CcSEcCtD
Duloxetine—Dyspepsia—Betamethasone—asthma	3.74e-05	9.85e-05	CcSEcCtD
Duloxetine—Urticaria—Triamcinolone—asthma	3.72e-05	9.79e-05	CcSEcCtD
Duloxetine—Urticaria—Methylprednisolone—asthma	3.71e-05	9.77e-05	CcSEcCtD
Duloxetine—Body temperature increased—Triamcinolone—asthma	3.7e-05	9.75e-05	CcSEcCtD
Duloxetine—Oedema—Prednisone—asthma	3.7e-05	9.74e-05	CcSEcCtD
Duloxetine—Anaphylactic shock—Prednisone—asthma	3.7e-05	9.74e-05	CcSEcCtD
Duloxetine—Abdominal pain—Methylprednisolone—asthma	3.69e-05	9.72e-05	CcSEcCtD
Duloxetine—Decreased appetite—Betamethasone—asthma	3.69e-05	9.72e-05	CcSEcCtD
Duloxetine—Decreased appetite—Dexamethasone—asthma	3.69e-05	9.72e-05	CcSEcCtD
Duloxetine—Infection—Prednisone—asthma	3.68e-05	9.68e-05	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Dexamethasone—asthma	3.67e-05	9.66e-05	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Betamethasone—asthma	3.67e-05	9.66e-05	CcSEcCtD
Duloxetine—Hypersensitivity—Hydrocortisone—asthma	3.66e-05	9.65e-05	CcSEcCtD
Duloxetine—Fatigue—Betamethasone—asthma	3.66e-05	9.65e-05	CcSEcCtD
Duloxetine—Fatigue—Dexamethasone—asthma	3.66e-05	9.65e-05	CcSEcCtD
Duloxetine—Shock—Prednisone—asthma	3.64e-05	9.59e-05	CcSEcCtD
Duloxetine—Pain—Betamethasone—asthma	3.63e-05	9.57e-05	CcSEcCtD
Duloxetine—Pain—Dexamethasone—asthma	3.63e-05	9.57e-05	CcSEcCtD
Duloxetine—Nervous system disorder—Prednisone—asthma	3.63e-05	9.55e-05	CcSEcCtD
Duloxetine—Tachycardia—Prednisone—asthma	3.61e-05	9.51e-05	CcSEcCtD
Duloxetine—Skin disorder—Prednisone—asthma	3.59e-05	9.46e-05	CcSEcCtD
Duloxetine—Hyperhidrosis—Prednisone—asthma	3.58e-05	9.42e-05	CcSEcCtD
Duloxetine—Asthenia—Hydrocortisone—asthma	3.57e-05	9.39e-05	CcSEcCtD
Duloxetine—Anorexia—Prednisone—asthma	3.53e-05	9.29e-05	CcSEcCtD
Duloxetine—Pruritus—Hydrocortisone—asthma	3.52e-05	9.26e-05	CcSEcCtD
Duloxetine—Feeling abnormal—Betamethasone—asthma	3.5e-05	9.22e-05	CcSEcCtD
Duloxetine—Feeling abnormal—Dexamethasone—asthma	3.5e-05	9.22e-05	CcSEcCtD
Duloxetine—Gastrointestinal pain—Betamethasone—asthma	3.47e-05	9.15e-05	CcSEcCtD
Duloxetine—Gastrointestinal pain—Dexamethasone—asthma	3.47e-05	9.15e-05	CcSEcCtD
Duloxetine—Hypersensitivity—Triamcinolone—asthma	3.45e-05	9.08e-05	CcSEcCtD
Duloxetine—Hypersensitivity—Methylprednisolone—asthma	3.44e-05	9.06e-05	CcSEcCtD
Duloxetine—Diarrhoea—Hydrocortisone—asthma	3.4e-05	8.96e-05	CcSEcCtD
Duloxetine—Urticaria—Betamethasone—asthma	3.38e-05	8.89e-05	CcSEcCtD
Duloxetine—Urticaria—Dexamethasone—asthma	3.38e-05	8.89e-05	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Prednisone—asthma	3.37e-05	8.88e-05	CcSEcCtD
Duloxetine—Dizziness—Prednisolone—asthma	3.37e-05	8.87e-05	CcSEcCtD
Duloxetine—Asthenia—Triamcinolone—asthma	3.36e-05	8.85e-05	CcSEcCtD
Duloxetine—Abdominal pain—Betamethasone—asthma	3.36e-05	8.84e-05	CcSEcCtD
Duloxetine—Abdominal pain—Dexamethasone—asthma	3.36e-05	8.84e-05	CcSEcCtD
Duloxetine—Body temperature increased—Dexamethasone—asthma	3.36e-05	8.84e-05	CcSEcCtD
Duloxetine—Body temperature increased—Betamethasone—asthma	3.36e-05	8.84e-05	CcSEcCtD
Duloxetine—Asthenia—Methylprednisolone—asthma	3.35e-05	8.83e-05	CcSEcCtD
Duloxetine—Insomnia—Prednisone—asthma	3.35e-05	8.81e-05	CcSEcCtD
Duloxetine—Paraesthesia—Prednisone—asthma	3.32e-05	8.75e-05	CcSEcCtD
Duloxetine—Pruritus—Triamcinolone—asthma	3.31e-05	8.72e-05	CcSEcCtD
Duloxetine—Pruritus—Methylprednisolone—asthma	3.31e-05	8.7e-05	CcSEcCtD
Duloxetine—Dizziness—Hydrocortisone—asthma	3.29e-05	8.66e-05	CcSEcCtD
Duloxetine—Dyspepsia—Prednisone—asthma	3.26e-05	8.58e-05	CcSEcCtD
Duloxetine—Decreased appetite—Prednisone—asthma	3.22e-05	8.47e-05	CcSEcCtD
Duloxetine—Rash—Prednisolone—asthma	3.21e-05	8.45e-05	CcSEcCtD
Duloxetine—Dermatitis—Prednisolone—asthma	3.21e-05	8.45e-05	CcSEcCtD
Duloxetine—Diarrhoea—Methylprednisolone—asthma	3.2e-05	8.42e-05	CcSEcCtD
Duloxetine—Fatigue—Prednisone—asthma	3.19e-05	8.4e-05	CcSEcCtD
Duloxetine—Headache—Prednisolone—asthma	3.19e-05	8.4e-05	CcSEcCtD
Duloxetine—Constipation—Prednisone—asthma	3.16e-05	8.33e-05	CcSEcCtD
Duloxetine—Vomiting—Hydrocortisone—asthma	3.16e-05	8.33e-05	CcSEcCtD
Duloxetine—Rash—Hydrocortisone—asthma	3.14e-05	8.26e-05	CcSEcCtD
Duloxetine—Dermatitis—Hydrocortisone—asthma	3.13e-05	8.25e-05	CcSEcCtD
Duloxetine—Headache—Hydrocortisone—asthma	3.12e-05	8.2e-05	CcSEcCtD
Duloxetine—Dizziness—Triamcinolone—asthma	3.1e-05	8.15e-05	CcSEcCtD
Duloxetine—Dizziness—Methylprednisolone—asthma	3.09e-05	8.13e-05	CcSEcCtD
Duloxetine—Feeling abnormal—Prednisone—asthma	3.05e-05	8.03e-05	CcSEcCtD
Duloxetine—Asthenia—Betamethasone—asthma	3.05e-05	8.03e-05	CcSEcCtD
Duloxetine—Asthenia—Dexamethasone—asthma	3.05e-05	8.03e-05	CcSEcCtD
Duloxetine—Gastrointestinal pain—Prednisone—asthma	3.03e-05	7.97e-05	CcSEcCtD
Duloxetine—Nausea—Prednisolone—asthma	3.02e-05	7.96e-05	CcSEcCtD
Duloxetine—Pruritus—Betamethasone—asthma	3.01e-05	7.91e-05	CcSEcCtD
Duloxetine—Pruritus—Dexamethasone—asthma	3.01e-05	7.91e-05	CcSEcCtD
Duloxetine—Vomiting—Triamcinolone—asthma	2.98e-05	7.84e-05	CcSEcCtD
Duloxetine—Vomiting—Methylprednisolone—asthma	2.97e-05	7.82e-05	CcSEcCtD
Duloxetine—Nausea—Hydrocortisone—asthma	2.95e-05	7.78e-05	CcSEcCtD
Duloxetine—Rash—Triamcinolone—asthma	2.95e-05	7.77e-05	CcSEcCtD
Duloxetine—Dermatitis—Triamcinolone—asthma	2.95e-05	7.77e-05	CcSEcCtD
Duloxetine—Rash—Methylprednisolone—asthma	2.95e-05	7.76e-05	CcSEcCtD
Duloxetine—Dermatitis—Methylprednisolone—asthma	2.94e-05	7.75e-05	CcSEcCtD
Duloxetine—Urticaria—Prednisone—asthma	2.94e-05	7.74e-05	CcSEcCtD
Duloxetine—Headache—Triamcinolone—asthma	2.93e-05	7.72e-05	CcSEcCtD
Duloxetine—Headache—Methylprednisolone—asthma	2.93e-05	7.71e-05	CcSEcCtD
Duloxetine—Body temperature increased—Prednisone—asthma	2.92e-05	7.7e-05	CcSEcCtD
Duloxetine—Abdominal pain—Prednisone—asthma	2.92e-05	7.7e-05	CcSEcCtD
Duloxetine—Diarrhoea—Dexamethasone—asthma	2.91e-05	7.65e-05	CcSEcCtD
Duloxetine—Diarrhoea—Betamethasone—asthma	2.91e-05	7.65e-05	CcSEcCtD
Duloxetine—Dizziness—Betamethasone—asthma	2.81e-05	7.4e-05	CcSEcCtD
Duloxetine—Dizziness—Dexamethasone—asthma	2.81e-05	7.4e-05	CcSEcCtD
Duloxetine—Nausea—Triamcinolone—asthma	2.78e-05	7.32e-05	CcSEcCtD
Duloxetine—Nausea—Methylprednisolone—asthma	2.78e-05	7.31e-05	CcSEcCtD
Duloxetine—Hypersensitivity—Prednisone—asthma	2.73e-05	7.18e-05	CcSEcCtD
Duloxetine—Vomiting—Dexamethasone—asthma	2.7e-05	7.11e-05	CcSEcCtD
Duloxetine—Vomiting—Betamethasone—asthma	2.7e-05	7.11e-05	CcSEcCtD
Duloxetine—Rash—Dexamethasone—asthma	2.68e-05	7.05e-05	CcSEcCtD
Duloxetine—Rash—Betamethasone—asthma	2.68e-05	7.05e-05	CcSEcCtD
Duloxetine—Dermatitis—Betamethasone—asthma	2.68e-05	7.05e-05	CcSEcCtD
Duloxetine—Dermatitis—Dexamethasone—asthma	2.68e-05	7.05e-05	CcSEcCtD
Duloxetine—Headache—Betamethasone—asthma	2.66e-05	7.01e-05	CcSEcCtD
Duloxetine—Headache—Dexamethasone—asthma	2.66e-05	7.01e-05	CcSEcCtD
Duloxetine—Asthenia—Prednisone—asthma	2.65e-05	6.99e-05	CcSEcCtD
Duloxetine—Pruritus—Prednisone—asthma	2.62e-05	6.89e-05	CcSEcCtD
Duloxetine—Diarrhoea—Prednisone—asthma	2.53e-05	6.67e-05	CcSEcCtD
Duloxetine—Nausea—Betamethasone—asthma	2.52e-05	6.65e-05	CcSEcCtD
Duloxetine—Nausea—Dexamethasone—asthma	2.52e-05	6.65e-05	CcSEcCtD
Duloxetine—Dizziness—Prednisone—asthma	2.45e-05	6.44e-05	CcSEcCtD
Duloxetine—Vomiting—Prednisone—asthma	2.35e-05	6.19e-05	CcSEcCtD
Duloxetine—Rash—Prednisone—asthma	2.33e-05	6.14e-05	CcSEcCtD
Duloxetine—Dermatitis—Prednisone—asthma	2.33e-05	6.14e-05	CcSEcCtD
Duloxetine—Headache—Prednisone—asthma	2.32e-05	6.1e-05	CcSEcCtD
Duloxetine—Nausea—Prednisone—asthma	2.2e-05	5.79e-05	CcSEcCtD
Duloxetine—HTR2A—Signaling Pathways—STAT6—asthma	1.87e-05	0.000105	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CCR3—asthma	1.87e-05	0.000104	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—C3—asthma	1.86e-05	0.000104	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ALDH7A1—asthma	1.86e-05	0.000104	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—EDN1—asthma	1.85e-05	0.000104	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—VEGFA—asthma	1.85e-05	0.000103	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—KNG1—asthma	1.84e-05	0.000103	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CCL5—asthma	1.84e-05	0.000103	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—POMC—asthma	1.84e-05	0.000103	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—IL2RB—asthma	1.83e-05	0.000103	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—AGTR1—asthma	1.83e-05	0.000103	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—STAT3—asthma	1.83e-05	0.000102	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—NPY—asthma	1.82e-05	0.000102	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—PDE4D—asthma	1.82e-05	0.000102	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CSF2—asthma	1.81e-05	0.000101	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CCL2—asthma	1.8e-05	0.000101	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—IL6R—asthma	1.79e-05	0.0001	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CXCL10—asthma	1.79e-05	0.0001	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ARG2—asthma	1.78e-05	9.98e-05	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—RHOA—asthma	1.78e-05	9.98e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—ITPR1—asthma	1.78e-05	9.96e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—PDE4B—asthma	1.77e-05	9.92e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—C5—asthma	1.77e-05	9.92e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—TACR1—asthma	1.77e-05	9.92e-05	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—CXCL8—asthma	1.77e-05	9.91e-05	CbGpPWpGaD
Duloxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—asthma	1.76e-05	9.88e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—PPP2CA—asthma	1.76e-05	9.87e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—NTRK1—asthma	1.76e-05	9.83e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—AGTR2—asthma	1.75e-05	9.82e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ARG1—asthma	1.74e-05	9.75e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—ADRB2—asthma	1.74e-05	9.73e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CCR5—asthma	1.73e-05	9.69e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—IL2RA—asthma	1.71e-05	9.55e-05	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—TGFB1—asthma	1.7e-05	9.5e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—C3—asthma	1.69e-05	9.47e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—EDN1—asthma	1.68e-05	9.41e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—EDNRB—asthma	1.68e-05	9.41e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CCL5—asthma	1.67e-05	9.34e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—TAC1—asthma	1.66e-05	9.31e-05	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—EGFR—asthma	1.66e-05	9.31e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—NPS—asthma	1.66e-05	9.31e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—PLA2G4A—asthma	1.66e-05	9.3e-05	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CCR5—asthma	1.66e-05	9.27e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—ITPR1—asthma	1.64e-05	9.2e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CSF2—asthma	1.64e-05	9.2e-05	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—IL2RA—asthma	1.63e-05	9.13e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CXCR3—asthma	1.63e-05	9.13e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CCR3—asthma	1.62e-05	9.07e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—RHOA—asthma	1.62e-05	9.06e-05	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—C3—asthma	1.62e-05	9.06e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CYBA—asthma	1.58e-05	8.84e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—NPY—asthma	1.58e-05	8.84e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ALDH7A1—asthma	1.58e-05	8.82e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CD86—asthma	1.57e-05	8.76e-05	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—CXCL8—asthma	1.57e-05	8.76e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—EDN1—asthma	1.55e-05	8.7e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—PARP1—asthma	1.55e-05	8.66e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—IL5—asthma	1.55e-05	8.66e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CCL5—asthma	1.54e-05	8.63e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—PLA2G4A—asthma	1.54e-05	8.6e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—PPP2CA—asthma	1.53e-05	8.57e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—AGTR2—asthma	1.52e-05	8.53e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CSF2—asthma	1.52e-05	8.5e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ARG2—asthma	1.51e-05	8.46e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CCR5—asthma	1.5e-05	8.41e-05	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—IL2—asthma	1.5e-05	8.37e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—BDKRB2—asthma	1.49e-05	8.35e-05	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—POMC—asthma	1.49e-05	8.34e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—IL2RA—asthma	1.48e-05	8.29e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—SMAD3—asthma	1.48e-05	8.27e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ALOX5AP—asthma	1.48e-05	8.27e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ALOX15—asthma	1.48e-05	8.27e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—C3—asthma	1.47e-05	8.22e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—EDNRB—asthma	1.46e-05	8.17e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—TAC1—asthma	1.44e-05	8.09e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—NPS—asthma	1.44e-05	8.09e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—ADCY2—asthma	1.44e-05	8.08e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—IL3—asthma	1.44e-05	8.05e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CXCL8—asthma	1.42e-05	7.96e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CXCR3—asthma	1.42e-05	7.93e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—PPP2CA—asthma	1.41e-05	7.92e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—CHAT—asthma	1.41e-05	7.89e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CCR5—asthma	1.39e-05	7.77e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CYBA—asthma	1.37e-05	7.68e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—IL2RA—asthma	1.37e-05	7.66e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—IL2—asthma	1.36e-05	7.6e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—KNG1—asthma	1.36e-05	7.6e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—C3—asthma	1.36e-05	7.6e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—POMC—asthma	1.35e-05	7.57e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—AGTR1—asthma	1.35e-05	7.55e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—PARP1—asthma	1.34e-05	7.52e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—IL5—asthma	1.34e-05	7.52e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	1.32e-05	7.41e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CCL2—asthma	1.32e-05	7.41e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—PDGFB—asthma	1.32e-05	7.39e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—IL6R—asthma	1.32e-05	7.39e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CXCL10—asthma	1.32e-05	7.38e-05	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—RHOA—asthma	1.31e-05	7.35e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—BDKRB2—asthma	1.3e-05	7.25e-05	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—POMC—asthma	1.29e-05	7.24e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—NTRK1—asthma	1.29e-05	7.24e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—ADRB2—asthma	1.28e-05	7.17e-05	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—IL6—asthma	1.28e-05	7.16e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—LEP—asthma	1.26e-05	7.07e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ALOX5—asthma	1.26e-05	7.03e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—ADCY2—asthma	1.25e-05	7.02e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ALOX5AP—asthma	1.25e-05	7.01e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ALOX15—asthma	1.25e-05	7.01e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—IL3—asthma	1.25e-05	6.99e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—ITPR1—asthma	1.21e-05	6.78e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—CARM1—asthma	1.2e-05	6.71e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—CHAT—asthma	1.19e-05	6.68e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—RHOA—asthma	1.19e-05	6.67e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—FN1—asthma	1.19e-05	6.67e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—DCN—asthma	1.18e-05	6.61e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—KNG1—asthma	1.18e-05	6.6e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—POMC—asthma	1.17e-05	6.58e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—AGTR1—asthma	1.17e-05	6.56e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CD86—asthma	1.15e-05	6.45e-05	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CXCL8—asthma	1.15e-05	6.45e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CCL2—asthma	1.15e-05	6.43e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ALDH2—asthma	1.15e-05	6.43e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—IL6R—asthma	1.15e-05	6.42e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CXCL10—asthma	1.15e-05	6.41e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—EDN1—asthma	1.14e-05	6.4e-05	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—RHOA—asthma	1.14e-05	6.38e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CCL5—asthma	1.14e-05	6.35e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—PLA2G4A—asthma	1.13e-05	6.33e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—NTRK1—asthma	1.12e-05	6.29e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CSF2—asthma	1.12e-05	6.26e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—ADRB2—asthma	1.11e-05	6.22e-05	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—IL2—asthma	1.1e-05	6.17e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—GSTT1—asthma	1.09e-05	6.12e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—SMAD3—asthma	1.09e-05	6.09e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—POMC—asthma	1.09e-05	6.08e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ALOX5—asthma	1.06e-05	5.96e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CCL2—asthma	1.06e-05	5.94e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—IL6R—asthma	1.06e-05	5.93e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—ITPR1—asthma	1.05e-05	5.89e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CXCL8—asthma	1.05e-05	5.86e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—PPP2CA—asthma	1.04e-05	5.83e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—EGFR—asthma	1.04e-05	5.81e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—RHOA—asthma	1.04e-05	5.79e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CCR5—asthma	1.02e-05	5.72e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—CARM1—asthma	1.02e-05	5.68e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—IL2RA—asthma	1.01e-05	5.64e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CD86—asthma	1e-05	5.6e-05	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CXCL8—asthma	1e-05	5.6e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—DCN—asthma	1e-05	5.6e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—IL2—asthma	1e-05	5.6e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—C3—asthma	9.99e-06	5.59e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—EDN1—asthma	9.93e-06	5.56e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—SERPINE1—asthma	9.91e-06	5.55e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CCL5—asthma	9.86e-06	5.52e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—PLA2G4A—asthma	9.82e-06	5.5e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ALDH2—asthma	9.73e-06	5.45e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—PDGFB—asthma	9.73e-06	5.44e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CSF2—asthma	9.71e-06	5.43e-05	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—IL2—asthma	9.56e-06	5.35e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—RHOA—asthma	9.56e-06	5.35e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—NOS3—asthma	9.47e-06	5.3e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—SMAD3—asthma	9.45e-06	5.29e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—asthma	9.36e-06	5.24e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—LEP—asthma	9.3e-06	5.21e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—GSTT1—asthma	9.26e-06	5.18e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CXCL8—asthma	9.09e-06	5.09e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—NQO1—asthma	9.08e-06	5.08e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—PPP2CA—asthma	9.04e-06	5.06e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ADCY2—asthma	8.89e-06	4.98e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CCR5—asthma	8.88e-06	4.97e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—FN1—asthma	8.77e-06	4.91e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—IL2RA—asthma	8.75e-06	4.9e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—IL2—asthma	8.69e-06	4.86e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—C3—asthma	8.68e-06	4.86e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—asthma	8.53e-06	4.78e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—PDGFB—asthma	8.45e-06	4.73e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CXCL8—asthma	8.4e-06	4.7e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—LEP—asthma	8.08e-06	4.52e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—IL2—asthma	8.02e-06	4.49e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—POMC—asthma	7.99e-06	4.47e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—IL6—asthma	7.98e-06	4.47e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CCL2—asthma	7.82e-06	4.38e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—IL6R—asthma	7.8e-06	4.36e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—NQO1—asthma	7.7e-06	4.31e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—EGFR—asthma	7.65e-06	4.28e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—FN1—asthma	7.62e-06	4.26e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—MMP9—asthma	7.59e-06	4.25e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—GSTP1—asthma	7.58e-06	4.24e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—PTEN—asthma	7.55e-06	4.23e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ADCY2—asthma	7.53e-06	4.22e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—HMOX1—asthma	7.47e-06	4.18e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—asthma	7.47e-06	4.18e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ITPR1—asthma	7.45e-06	4.17e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—CAT—asthma	7.37e-06	4.13e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—SERPINE1—asthma	7.3e-06	4.09e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—RHOA—asthma	7.04e-06	3.94e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—NOS3—asthma	6.97e-06	3.9e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—GSTM1—asthma	6.96e-06	3.9e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—PLA2G4A—asthma	6.96e-06	3.9e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—POMC—asthma	6.94e-06	3.88e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—VEGFA—asthma	6.82e-06	3.82e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CCL2—asthma	6.79e-06	3.8e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—IL6R—asthma	6.77e-06	3.79e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—STAT3—asthma	6.75e-06	3.78e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—EGFR—asthma	6.64e-06	3.72e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—asthma	6.51e-06	3.64e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—GSTP1—asthma	6.42e-06	3.59e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—PPP2CA—asthma	6.41e-06	3.59e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—SERPINE1—asthma	6.34e-06	3.55e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—HMOX1—asthma	6.33e-06	3.54e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ITPR1—asthma	6.32e-06	3.53e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—TGFB1—asthma	6.26e-06	3.5e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—CAT—asthma	6.25e-06	3.5e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CXCL8—asthma	6.18e-06	3.46e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—EGFR—asthma	6.14e-06	3.43e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—RHOA—asthma	6.12e-06	3.42e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—NOS3—asthma	6.05e-06	3.39e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—IL2—asthma	5.91e-06	3.31e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—PLA2G4A—asthma	5.9e-06	3.3e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—GSTM1—asthma	5.9e-06	3.3e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—IL6—asthma	5.88e-06	3.29e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—MMP9—asthma	5.59e-06	3.13e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—PTEN—asthma	5.56e-06	3.11e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—PPP2CA—asthma	5.43e-06	3.04e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CXCL8—asthma	5.37e-06	3.01e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—IL2—asthma	5.13e-06	2.87e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—IL6—asthma	5.11e-06	2.86e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—VEGFA—asthma	5.02e-06	2.81e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—STAT3—asthma	4.97e-06	2.78e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—POMC—asthma	4.92e-06	2.75e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—MMP9—asthma	4.86e-06	2.72e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—PTEN—asthma	4.83e-06	2.7e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—IL6—asthma	4.72e-06	2.64e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—TGFB1—asthma	4.61e-06	2.58e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—EGFR—asthma	4.52e-06	2.53e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ALB—asthma	4.49e-06	2.51e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—VEGFA—asthma	4.36e-06	2.44e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—STAT3—asthma	4.32e-06	2.42e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—NOS3—asthma	4.29e-06	2.4e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—POMC—asthma	4.17e-06	2.33e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—TGFB1—asthma	4e-06	2.24e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—PTGS2—asthma	3.92e-06	2.2e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—EGFR—asthma	3.92e-06	2.2e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ALB—asthma	3.8e-06	2.13e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—NOS3—asthma	3.64e-06	2.03e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—IL6—asthma	3.47e-06	1.94e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—PTEN—asthma	3.42e-06	1.92e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—PTGS2—asthma	3.32e-06	1.86e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—IL6—asthma	3.02e-06	1.69e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—PTEN—asthma	2.9e-06	1.62e-05	CbGpPWpGaD
